{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:02:03Z","timestamp":1760346123326},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T00:00:00Z","timestamp":1256515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T00:00:00Z","timestamp":1256515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1111\/j.1365-2133.2009.09490.x","type":"journal-article","created":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T12:11:43Z","timestamp":1256559103000},"page":"29-41","source":"Crossref","is-referenced-by-count":9,"title":["Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity"],"prefix":"10.1093","volume":"162","author":[{"given":"H.","family":"Mitsui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Inozume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Shibagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,10,26]]},"reference":[{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2006.10.031","article-title":"The taming of the cell penetrating domain of the HIV tat: myths and realities","volume":"117","author":"Chauhan","year":"2007","journal-title":"J Control Release"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11095-007-9303-7","article-title":"Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives","volume":"24","author":"Patel","year":"2007","journal-title":"Pharm Res"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/cbic.200600171","article-title":"Molecular transporters: synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging","volume":"7","author":"Goun","year":"2006","journal-title":"ChemBioChem"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.addr.2004.10.005","article-title":"Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer","volume":"57","author":"Wadia","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2004.10.018","article-title":"Cationic TAT peptide transduction domain enters cells by macropinocytosis","volume":"102","author":"Kaplan","year":"2005","journal-title":"J Control Release"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1021\/bi035933x","article-title":"Pathway for polyarginine entry into mammalian cells","volume":"43","author":"Fuchs","year":"2004","journal-title":"Biochemistry"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejps.2005.10.011","article-title":"The kinetics and tissue distribution of protin transduction in mice","volume":"27","author":"Cai","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.yexcr.2005.12.029","article-title":"Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo","volume":"312","author":"Kim","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/sj.jid.5700335","article-title":"Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity","volume":"126","author":"Mitsui","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1038\/sj.jid.5700909","article-title":"Dendritic cells transduced with autoantigen FCRLA induce cytotoxic lymphocytes and vaccinate against murine B-cell lymphoma","volume":"127","author":"Inozume","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.vaccine.2003.12.023","article-title":"Induction of cytotoxic T lymphocytes following immunization with cationized soluble antigen","volume":"22","author":"Ikegawa","year":"2004","journal-title":"Vaccine"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vaccine.2006.07.017","article-title":"Induction of antigen-specific cytotoxic T lymphocytes by immunization with negatively charged soluble antigen through scavenger receptor-mediated delivery","volume":"25","author":"Yamasaki","year":"2007","journal-title":"Vaccine"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijantimicag.2004.09.005","article-title":"Antimicrobial peptides: premises and promises","volume":"24","author":"Reddy","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/138920307782411428","article-title":"Antimicrobial peptides in burns and wounds","volume":"8","author":"Bhat","year":"2007","journal-title":"Curr Protein Pept Sci"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-9255-3-14","article-title":"Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin","volume":"3","author":"Djanani","year":"2006","journal-title":"J Inflamm (Lond)"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1172\/JCI117594","article-title":"Cationic protein-induced sensory nerve activation: role of substance P in airway hyperresponsiveness and plasma protein extravasation","volume":"94","author":"Coyle","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1165\/ajrcmb.22.5.f183","article-title":"Cationic proteins and bronchial hyperresponsiveness","volume":"22","author":"Madison","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)80447-1","article-title":"Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody","volume":"6","author":"Porgador","year":"1997","journal-title":"Immunity"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.4049\/jimmunol.168.5.2393","article-title":"Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity","volume":"168","author":"Shibagaki","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.4049\/jimmunol.174.8.4880","article-title":"STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion","volume":"174","author":"Kusmartsev","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1084\/jem.20062056","article-title":"Induced sensitization of tumor stroma leads to eradication of established cancer by T cells","volume":"204","author":"Zhang","year":"2007","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ijc.20735","article-title":"Novel melanoma antigen, FCRL\/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients","volume":"114","author":"Inozume","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.166.8.5122","article-title":"The potency and durability of DNA-, and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge","volume":"166","author":"Mendez","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0092-8674(88)91043-4","article-title":"Introduction of soluble protein into the class I pathway of antigen processing and presentation","volume":"54","author":"Moore","year":"1988","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1084\/jem.190.5.617","article-title":"Distinct role of antigen-specific T helper type 1 (Th1) and Th2 in tumor eradication in vivo","volume":"190","author":"Nishimura","year":"1999","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/clim.1999.4724","article-title":"Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration","volume":"92","author":"Brockstedt","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4049\/jimmunol.164.2.916","article-title":"Type 1 and type 2 CD8+ effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor","volume":"164","author":"Dobrzanski","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.165.5.2651","article-title":"Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma","volume":"165","author":"Bellone","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/intimm\/dxg081","article-title":"A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific Th1 cells","volume":"15","author":"Sato","year":"2003","journal-title":"Int Immunol"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1158\/0008-5472.CAN-03-2596","article-title":"Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells","volume":"64","author":"Chamoto","year":"2004","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2009.09490.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1158\/0008-5472.CAN-04-0138","article-title":"Targeting dendritic cells with antigen-containing liposome: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy","volume":"64","author":"Van Broekhoven","year":"2004","journal-title":"Cancer Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09490.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09490.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09490.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:47:05Z","timestamp":1676382425000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/162\/1\/29\/6642703"}},"subtitle":["Polyarginine-containing immunogenic antigens and antitumour immunity"],"short-title":[],"issued":{"date-parts":[[2009,10,26]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09490.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10,26]]}}}